Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Generic and Biosimilar Cancer Medicines

The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")

This public procurement record has 2 releases in its history.

Award

21 Apr 2023 at 01:00

OJEU - F3 - Contract Award Notice
Tender

16 Sep 2022 at 01:00

OJEU - F2 - Contract Notice
Summary of the contracting process

The public procurement process is currently at the Tender stage for a contract titled "Supply of Office Furniture" in the industry category of Furniture and Home Furnishings. The buying organization is the Department of Government Services located in London. The deadline for submissions is set for 1st August 2022, providing an opportunity for businesses in the furniture industry to compete for this contract.

This tender presents growth opportunities for furniture suppliers looking to expand their business in the public sector. Companies specializing in office furniture are well-suited to compete in this procurement process. By meeting the submission deadline and demonstrating quality products, businesses can potentially secure a contract with the Department of Government Services, based in London.

How relevant is this notice?

Notice Information

Notice Title

Generic and Biosimilar Cancer Medicines

Notice Description

This Framework Agreement is for the supply of generic and biosimilar cancer medicines to NHS Scotland. The Goods were separated into forty-one (41) categories, each of which is identified as a "Lot". Full details of each awarded Lot is contained in section II.2 of this Notice.

Lot Information

Lot 1 Bendamustine Powder For Solution For Infusion

Supply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 2 Capecitabine Tablets

Supply of Capecitabine Tablets to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 3 Carboplatin Injection

Supply of Carboplatin Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 4 Cisplatin Injection

Supply of Cisplatin Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 5 Cyclophosphamide Injection, Powder For Reconstitution

Supply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 6 Cytarabine Injections

Supply of Cytarabine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 7 Dacarbazine Injections

Supply of Dacarbazine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 8 Disodium Folinate Injection

Supply of Disodium Folinate Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 9 Docetaxel Concentrate For Solution For Infusion

Supply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 10 Doxorubicin Hydrochloride Injections

Supply of Doxorubicin Hydrochloride Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 11 Fluorouracil 25MG/ML Injection

Supply of Fluorouracil 25MG/ML Injections to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 12 Fluorouracil 50MG/ML Injection

Supply of Fluorouracil 50MG/ML Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 13 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials

Supply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 14 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials

Supply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 15 Gemcitabine Powder For Solution For Infusion Vials

Supply of Gemcitabine Powder For Solution For Infusion Vials to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 16 Idarubicin Hydrochlioride Injection Powder For Reconstitution

Supply of Idarubicin Hydrochlioride Injection Powder For Reconstitution to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 17 Ifosfamide Injection Powder For Reconstitution

Supply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 18 Irinotecan Hydrochloride Injection

Supply of Irinotecan Hydrochloride Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 19 Lanreotide Injection Prefilled Syringes

Supply of Lanreotide Injection Prefilled Syringes to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 20 Methotrexate Without Preservatives Injection

Supply of Methotrexate Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 21 Methotrexate Oral Solution

Supply of Methotrexate Oral Solution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 22 Mitomycin Injection Powder For Reconstitution

Supply of Mitomycin Injection Powder For Reconstitution to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 23 Oxaliplatin Vial Solution

Supply of Oxaliplatin Vial Solution to NHS Scotland. The Authority has awarded presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 24 Paclitaxel Concentrate For Intravenous Infusion

Supply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 25 Temozolomide Capsules

Supply of Temozolomide Capsules to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 26 Vincristine Without Preservatives Injection

Supply of Vincristine Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 27 Vinorelbine Injection

Supply of Vinorelbine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 28 Aprepitant Capsules

Supply of Aprepitant Capsules to NHS Scotland. Each product line within this Lot was grouped together and awarded to a single Framework Participant.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 29 Topotecan Capsules

Supply of Topotecan Capsules to NHS Scotland. Each product line within this Lot will be grouped together and awarded to a single Framework Participant. Full details of Goods and volumes can be found within the ITT documents.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 30 Topotecan Concentrate For Solution For Infusion

Supply of Topotecan Concentrate For Solution For Infusion to NHS Scotland. Each product line within this Lot will be grouped together and awarded to a single Framework Participant. Full details of Goods and volumes can be found within the ITT documents

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 31 Octreotide Injection

Supply of Octreotide Injection. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 32 Filgrastim Pre-Filled Syringe

Supply of Filgrastim Pre-Filled Syringe to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 33 Pemetrexed Powder For Solution For Infusion Vials

Supply of Pemetrexed Powder For Solution For Infusion Vials in various presentations to NHS Scotland. The Authority has awarded this Lot as a single-supplier framework.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 34 Pemetrexed (25Mg/Ml) Solution For Infusion Vials

Supply of Pemetrexed (25Mg/Ml) Solution For Infusion Vials to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 35 Octreotide Vials Long Acting (Excluding Homecare)

Supply of Octreotide Vials Long Acting (Excluding Homecare) to NHS Scotland. The Authority intends awarding each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 3 Suppliers will be awarded.

Renewal: he Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 36 Octreotide Vials Long Acting (Including Homecare)

Supply of Octreotide Vials Long Acting (Including Homecare) to NHS Scotland. The Authority intends awarding each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 3 Suppliers will be awarded. Full details can be found within the ITT.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 37 Etoposide Injection

Supply of Etoposide Injection to NHS Scotland. The Authority has awarded this Lot as a ranked multi-supplier framework award

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 38 Dasatinib Tablets

Supply of Dasatinib Tablets to NHS Scotland. The Authority has awarded each product line as a multi-supplier ranked framework agreement to 2 framework participants.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines

Supply of a number of Generic & Biosimilar Medicines including bevacizumab solution for infusion, doxorubicin liposomal solution for infusion, rituximab solution for infusion, trastuzumab powder for solution for infusion, sorafenib tablets and thalidomide capsules to NHS Scotland. Each product line has been treated as an individual Lot and awarded as a unranked multi-supplier award

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 40 Idarubicin Hydrochloride Solution for Infusion

Supply of Idarubicin Hydrochloride Solution for Infusion. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 41 Single Supplier Generic Medicines

Supply of a range of generic cancer medicines to NHS Scotland. Each product line has been treated as an individual Lot and awarded to a single Framework Participant.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000705779
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR476816
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£59,145,973 £10M-£100M
Lots Value
£59,145,972 £10M-£100M
Awards Value
Not specified
Contracts Value
£33,350,281 £10M-£100M

Notice Dates

Publication Date
21 Apr 20233 years ago
Submission Deadline
17 Oct 2022Expired
Future Notice Date
Not specified
Award Date
23 Dec 20223 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Active, Complete
Awards Status
Not Specified
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland
Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
29
Supplier Names

Accord-UK Ltd

Aspen Pharmacare UK Limited

Baxter Healthcare Ltd

Bayer Plc

Celltrion Healthcare United Kingdom Limited

Chugai Pharma UK Ltd

Consilient Health Ltd

Dr Reddy's Laboratories (UK) Ltd

Flexipharm Austrading Limited

Fresenius Kabi Ltd

Glenmark Pharmaceuticals Europe Ltd

Intrapharm Laboratories Ltd

Kent Pharmaceuticals Ltd

Martindale Pharma

Mercury Pharma Group

Morningside Pharmaceuticals Limited

Neon Healthcare

Organon Pharmaceutical UK Ltd

Pfizer Ltd

Ranbaxy (UK) Ltd

Roche Products Ltd

Rosemont Pharmaceuticals Ltd

Sandoz Ltd

Selective Supplies Ltd

Teva UK Limited

Thornton & Ross

Viatris UK Healthcare Ltd

Zentiva Pharma UK Ltd

medac Pharma LLP

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...